Heparan Sulfate in the Tumor Microenvironment.

Adhesion Angiogenesis Cancer Cell growth Extracellular matrix Glycosaminoglycan Growth factor Heparan sulfate Heparanase Inflammation Invasion Metastasis Proteoglycan Tumor UDP-sugars

Journal

Advances in experimental medicine and biology
ISSN: 0065-2598
Titre abrégé: Adv Exp Med Biol
Pays: United States
ID NLM: 0121103

Informations de publication

Date de publication:
2020
Historique:
entrez: 9 4 2020
pubmed: 9 4 2020
medline: 18 4 2020
Statut: ppublish

Résumé

The biology of tumor cells strictly depends on their microenvironment architecture and composition, which controls the availability of growth factors and signaling molecules. Thus, the network of glycosaminoglycans, proteoglycans, and proteins known as extracellular matrix (ECM) that surrounds the cells plays a central role in the regulation of tumor fate. Heparan sulfate (HS) and heparan sulfate proteoglycans (HSPGs) are highly versatile ECM components that bind and regulate the activity of growth factors, cell membrane receptors, and other ECM molecules. These HS binding partners modulate cell adhesion, motility, and proliferation that are processes altered during tumor progression. Modification in the expression and activity of HS, HSPGs, and the respective metabolic enzymes results unavoidably in alteration of tumor cell microenvironment. In this light, the targeting of HS structure and metabolism is potentially a new tool in the treatment of different cancer types.

Identifiants

pubmed: 32266657
doi: 10.1007/978-3-030-40146-7_7
doi:

Substances chimiques

Heparan Sulfate Proteoglycans 0
Heparitin Sulfate 9050-30-0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-161

Auteurs

Barbara Bartolini (B)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Elena Caravà (E)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Ilaria Caon (I)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Arianna Parnigoni (A)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Paola Moretto (P)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Alberto Passi (A)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Davide Vigetti (D)

Department of Medicine and Surgery, University of Insubria, Varese, Italy.

Manuela Viola (M)

Department of Medicine and Surgery, University of Insubria, Varese, Italy. Manuela.viola@uninsubria.it.

Evgenia Karousou (E)

Department of Medicine and Surgery, University of Insubria, Varese, Italy. jenny.karousou@uninsubria.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH